Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SC RopharmaBSE:RPH 66 OCF Yield % is 43.07 as of Jul. 14, 2026, which is 210% above its 10-year median of 13.89. GuruFocus rates BSE:RPH with a GF Score™ of 66/100.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
SC Ropharma OCF Yield % Related Terms
SC Ropharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for SC Ropharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, SC Ropharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SC Ropharma OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where SC Ropharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SC Ropharma (BSE:RPH) has a OCF Yield % of 43.07 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SC Ropharma and its competitors. This is 210% above median its historical median of 13.89.
Is SC Ropharma's OCF Yield % too high?
SC Ropharma's current OCF Yield % of 43.07 is 210% above median its 10-year median of 13.89. The Healthcare Providers & Services industry median OCF Yield % is 5.47. SC Ropharma's value of 43.07 is 687.4% above this industry median. Overall, SC Ropharma has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does SC Ropharma's OCF Yield % compare to competitors?
SC Ropharma's OCF Yield % of 43.07 can be compared against companies in the Healthcare Providers & Services industry. The industry median OCF Yield % is 5.47. SC Ropharma's value of 43.07 is 687.4% above this benchmark. While the company's 10-year median is 13.89 vs. the industry median of 5.47, SC Ropharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SC Ropharma's current OCF Yield % of 43.07 is 687.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SC Ropharma and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SC Ropharma's current OCF Yield % is 43.07, which is 210% above median its own 10-year median of 13.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SC Ropharma stock overvalued right now?
SC Ropharma (BSE:RPH) has a current OCF Yield % of 43.07. The current OCF Yield % is 43.07, which is 210% above median its 10-year median of 13.89 and 687.4% above the Healthcare Providers & Services industry median of 5.47. SC Ropharma's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For SC Ropharma (BSE:RPH), the current OCF Yield % is 43.07 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
66GF Score
Get the complete analysis for BSE:RPH
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:RPH has been successfully added to your 
